Farsa | phenylalanyl-tRNA synthetase, alpha subunit
Physiological systems
17 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Homeostasis/metabolism Immune system Hematopoietic system Skeleton Mortality/aging
12 No significant impact
7 Not tested
Data collections
Gene metrics:8Significant phenotypes
1Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| increased circulating insulin level | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 5.06x10-7 | ||
| decreased bone mineral content | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 3.52x10-6 | ||
| decreased circulating sodium level | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 2.3x10-7 | ||
| preweaning lethality, complete penetrance | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | homozygote | Early adult | N/A * | ||
| impaired glucose tolerance | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 2.97x10-6 | ||
| decreased leukocyte cell number | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 9.08x10-5 | ||
| decreased circulating chloride level | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 1.66x10-7 | ||
| decreased bone mineral density | 1 supporting dataset | Farsatm2a(EUCOMM)Wtsi | heterozygote | Early adult | 2.77x10-7 |
| | | | | | | | | | |
External links
No external links available for Farsa.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| Farsatm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | es cell |
| Farsatm2a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell mouse |